113 related articles for article (PubMed ID: 17846598)
41. Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Nakasone H; Kanda Y; Ueda T; Matsumoto K; Shimizu N; Minami J; Sakai R; Hagihara M; Yokota A; Oshima K; Tsukada Y; Tachibana T; Nakaseko C; Fujisawa S; Yano S; Fujita H; Takahashi S; Kanamori H; Okamoto S;
Am J Hematol; 2009 Dec; 84(12):809-14. PubMed ID: 19862826
[TBL] [Abstract][Full Text] [Related]
42. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
43. Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.
Tricot G; Barlogie B; Zangari M; van Rhee F; Hoering A; Szymonifka J; Cottler-Fox M
Haematologica; 2008 Nov; 93(11):1739-42. PubMed ID: 18728024
[TBL] [Abstract][Full Text] [Related]
44. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
[TBL] [Abstract][Full Text] [Related]
45. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
46. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
47. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
[TBL] [Abstract][Full Text] [Related]
48. Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.
Babatunde AS; Tan DC; Heng KK; Lee JJ; Loh YS; Hwang WY; Koh MB; Goh YT; Linn YC
Bone Marrow Transplant; 2009 Aug; 44(3):175-83. PubMed ID: 19204715
[TBL] [Abstract][Full Text] [Related]
49. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
50. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
52. Rapid engraftment at a cost?
Goldberg JD; Vogelsang GB
Transplantation; 2010 Nov; 90(9):949-50. PubMed ID: 20802399
[No Abstract] [Full Text] [Related]
53. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
54. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases.
Wang HX; Yan HM; Duan LN; Wang ZD; Zhu L; Xue M; Liu J; Hu LD; Guo ZK
Pediatr Hematol Oncol; 2009; 26(3):119-28. PubMed ID: 19382033
[TBL] [Abstract][Full Text] [Related]
55. Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT.
Inukai T; Goi K; Tezuka T; Uno K; Nemoto A; Takahashi K; Sato H; Akahane K; Hirose K; Honna H; Kuroda I; Kagami K; Nakamoto K; Taniguchi K; Nakazawa S; Sugita K
Bone Marrow Transplant; 2009 Feb; 43(3):229-35. PubMed ID: 18806835
[TBL] [Abstract][Full Text] [Related]
56. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
57. Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report.
Fang B; Song YP; Li N; Li J; Han Q; Zhao RC
Transplant Proc; 2009 Jun; 41(5):1827-30. PubMed ID: 19545737
[TBL] [Abstract][Full Text] [Related]
58. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
[TBL] [Abstract][Full Text] [Related]
59. Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.
Palladini G; Kyle RA; Larson DR; Therneau TM; Merlini G; Gertz MA
Amyloid; 2005 Jun; 12(2):120-6. PubMed ID: 16011989
[TBL] [Abstract][Full Text] [Related]
60. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
